Next Article in Journal
Regioselective Synthesis of Coumarin-Annulated Polycyclic Heterocycles via Sequential Claisen Rearrangement and Radical Cyclization Reaction
Previous Article in Journal
Efficient Synthesis of Substituted 2-Nitrochalcone Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Multicomponent One-Pot Synthesis of Imidazo[1,2-a]pyridine Functionalized with Azides †

by
Diana García-García
1,
Jorge Alejandro Tovar-Rosales
1,
Indhira A. González-Gámez
2 and
Rocío Gámez-Montaño
1,*
1
Departamento de Química, Universidad de Guanajuato, Noria Alta S/N, Col. Noria Alta, Guanajuato 36050, Mexico
2
Campus Querétaro, Arkansas State University, km 17.5 Estatal 100, Colón 76270, Mexico
*
Author to whom correspondence should be addressed.
Presented at the 28th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-28), 15–30 November 2024; Available online: https://sciforum.net/event/ecsoc-28.
Chem. Proc. 2024, 16(1), 88; https://doi.org/10.3390/ecsoc-28-20140
Published: 14 November 2024

Abstract

:
Imidazo[1,2-a]pyridines (IMPs) are valuable heterocycles, present in bioactive compounds and drugs. Analogs that incorporate azide moieties are useful intermediates in organic synthesis and can be used as synthetic platforms to access more complex products. Isocyanide-based multicomponent reactions such as Groebke–Blackburn–Bienaymé (GBB-3CR) are versatile tools to synthesized IMPs, in which orthogonal reagents are included into components to increase its synthetic potential. Herein we developed a one-pot process to access IMPs functionalized with azides under mild conditions, which are synthetic platforms for further post-transformations.

1. Introduction

Imidazo[1,2-a]pyridines are nitrogen-fused heterocycles, which are acknowledged as privileged molecules due their wide range of properties in medicinal chemistry, including anti-diabetic, anti-cancer, anti-viral, anti-ulcer, anti-microbial, anti-IHV, hypnotic, analgesic, and antipyretic activities (Figure 1) [1]. These scaffolds are also valuable for other fields like bioimaging, probes, or chemosensors, due to their optoelectronic properties, which include high quantum yields, large Stokes shifts, and good stability [2,3].
On the other hand, organic azides are valuable intermediates in organic synthesis for constructing diverse nitrogen-containing heterocycles via intra- or intermolecular C-N and N-N bond formation; these are not found in nature, and to our knowledge, only the anti-viral drug zidovudine incorporates this group (Figure 1) [4].
One-pot processes that include multicomponent reactions are the most efficient, robust, and sustainable synthetic tools for the synthesis of valuable molecules. Among these, isocyanide-based multicomponent reactions stand out as the most versatile and effective tools for the synthesis of heterocyclic molecules directly or via post-transformation. Specifically, the Groebke–Blackburn–Bienaymé reaction (GBB-3CR) is the most effective tool for accessing IMPs. This reaction involves an aldehyde or ketone, an amidine, and an isocyanide, with Lewis or Bronsted acid catalysis. The reactivity of the endocyclic nitrogen in the amidine component allows intramolecular nitrilium ion trapping, leading to the formation of the heterocyclic scaffold, whereas the acid component is not incorporated in the final products as in the classical Ugi reaction [5,6,7].
Herein we developed one-pot synthesis under mild conditions to access IMPs functionalized with azides, using ammonium chlorine as a catalyst (Scheme 1). The resulting GBB products could serve as synthetic platforms for further post-transformations.

2. Results and Discussion

The synthesis of imidazo[1,2-a]pyridine (9a) was made via a GBB-3CR reaction between 2-azidobenzaldehyde (6), 2-aminopyridine (7), and tert-butyl isocyanide (8a), in the solvent MeOH. We used green catalysts, ammonium chloride, and p-toluensulfonic acid, which resulted in moderate yields at room temperature (Table 1, entries 1–2). Since a higher yield was obtained with ammonium chloride, it was selected for the synthesis of GBB-3CR product.
In Scheme 2, a series of imidazo[1,2-a]pyridine (9ad) is depicted, which was synthesized under the optimized conditions. The effect of the stereo-electronic nature of the isocyanide component was evaluated, employing aliphatic and aromatic isocyanides. Finally, products were obtained in moderate yields (58%–69%).

3. Experimental Section

3.1. General Information, Intrumentation and Chemicals

1H and 13C NMR spectra were acquired on a Bruker Advance III spectrometer (500 MHz). The solvent used for NMR spectroscopy was deuterated chloroform (CDCl3). Chemical shifts (δ) are given in ppm relative to tetramethylsilane (TMS). Coupling constants are reported in Hertz (Hz). Multiplicities of the signals are reported using standard abbreviations: singlet (s), doublet (d), triplet (t), quartet (q), and multiplet (m). NMR spectra were analyzed using MestReNova software version 14.2.0-26256. Reaction progress was monitored by thin-layer chromatography (TLC) on pre-coated silica gel F254 aluminum sheets, and the spots were visualized under UV light at 254 nm. Column chromatography was performed using silica gel (230–400 mesh) as a stationary phase. Mixtures of hexanes and ethyl acetate were used as a mobile phase for column chromatography and in TLC for reaction progress monitoring and measuring retention factors (Rf). All reagents were purchased from Sigma Aldrich and were used without purification.

3.2. General Procedure

In a sealed vial, 2-azidobenzaldehyde (6, 1.0 equiv.), 2-aminopyridine (7, 1.0 equiv.), isocyanide (8ad, 1.0 equiv.), and ammonium chloride (0.2 equiv.) were dissolved in MeOH (1.0 M) and stirred at room temperature for 24 h. The solvent was removed, and the crude was purified by flash chromatography using silica gel and mixtures of ethyl acetate in hexanes as the mobile phase and silica gel as the stationary phase to afford the corresponding imidazo[1,2-a]pyridine (9ad).

3.3. Spectral Data

Chemproc 16 00088 i002
  • 2-(2-azidophenyl)-N-(tert-butyl)imidazo[1,2-a]pyridine-3-amine (9a).
Brown oil, Rf = 0.24 (40 % ethyl acetate in hexanes), 1H (500 MHz, CDCl3, 25 °C, TMS): δ 8.37–8.26 (m, 1H), 7.82–7.75 (m, 1H), 7.75–7.67 (m, 1H), 7.42–7.36 (m, 1H), 7.26–7.18 (m, 3H), 6.90–6.80 (m, 1H), 3.60 (s, 1H), 0.88 (s, 9H); 13C NMR (125 MHz, CDCl3) 141.6, 137.0, 134.8, 132.3, 129.5, 126.4, 125.5, 125.3, 125.1, 123.7, 118.2, 116.7, 112.0, 56.0, 29.8.
Chemproc 16 00088 i003
  • 2-(2-azidophenyl)-N-cyclohexylimidazo[1,2-a]pyridine-3-amine (9b).
Brown oil, Rf = 0.24 (40 % ethyl acetate in hexanes), 1H (500 MHz, CDCl3, 25 °C, TMS): δ 8.13 (dt, J = 6.9, 1.3 Hz, 1H), 7.78 (dd, J = 7.7, 1.7 Hz, 1H), 7.54 (dd, J = 9.1, 1.3 Hz, 1H), 7.43 (td, J = 7.7, 1.6 Hz, 1H), 7.30-7.24 (m, 2H), 7.13 (dd, J = 9.1, 1.3 Hz, 1H), 6.80 (td, J = 6.7, 1.2 Hz, 1H), 3.78–3.71 (m, 1H), 2.68–2.61 (m,1H), 1.74–1.69 (m, 1H), 1.64–1.56 (m, 2H), 1.52–1.45 (m, 1H), 1.15–0.97 (m, 5H); 13C NMR (125 MHz, CDCl3) 142.0, 137.0, 133.7, 132.5, 129.2, 127.2, 126.7, 125.5, 123.8, 123.0, 118.4, 117.6, 111.7, 56.8, 34.2, 25.8, 24.9.
Chemproc 16 00088 i004
  • 2-(2-azidophenyl)-N-(2,6-dimethylphenyl)imidazo[1,2-a]pyridine-3-amine (9c).
Brown oil, Rf = 0.19 (40 % ethyl acetate in hexanes), 1H (500 MHz, CDCl3, 25 °C, TMS): δ 7.64 (dt, J = 6.8, 1.2 Hz, 1H), 7.61–7.57 (m, 2H), 7.38–7.34 (m, 1H), 7.20–7.11 (m, 3H), 6.88 (d, J = 7.4 Hz, 2H), 6.76–6.69 (m, 2H), 5.75 (s, 1H), 1.91 (s, 6H); 13C NMR (125 MHz, CDCl3) 141.4, 139.9, 137.8, 134.3, 131.9, 129.5, 129.4, 126.8, 126.4, 125.2, 123.7, 123.1, 122.4, 121.6, 118.2, 117.9, 112.3, 18.4.
Chemproc 16 00088 i005
  • 2-(2-azidophenyl)-N-(4-methoxyphenyl)imidazo[1,2-a]pyridine-3-amine (9d).
Brown oil, Rf = 0.17 (40 % ethyl acetate in hexanes), 1H (500 MHz, CDCl3, 25 °C, TMS): δ 7.80 (dt, J = 6.7, 1.2 Hz, 1H), 7.72 (dd, J = 7.7, 1.6 Hz, 1H), 7.65 (dt, J = 9.1, 1.1 Hz, 1H), 7.40–7.34 (m, 1H), 7.24–7.16 (m, 3H), 6.78 (td, J = 6.7, 1.1 Hz, 1H), 6.72 (d, J = 8.9 Hz, 2H), 6.42 (d, J = 9.0 Hz, 2H), 5.97 (s, 1H), 3.70 (s, 3H); 13C NMR (125 MHz, CDCl3) 153.6, 142.6, 138.3, 137.5, 135.5, 132.2, 129.6, 126.1, 125.3, 124.6, 123.3, 121.4, 118.6, 117.9, 115.2, 115.1, 112.2, 55.8.

4. Conclusions

Finally, the present work contributes in the design and development of novel green multicomponent one-pot synthesis via GBB-3CR, under mild conditions. The orthogonal reagents in GBB-3CR allow for the increased synthetic potential of a series of imidazo[1,2-a]pyridine functionalized with azides.

Author Contributions

Conceptualization, R.G.-M.; methodology, D.G.-G., J.A.T.-R., and I.A.G.-G.; software, D.G.-G.; validation, R.G.-M.; formal analysis, R.G.-M.; investigation, D.G.-G.; resources, R.G.-M.; data curation, D.G.-G.; writing—original draft preparation, D.G.-G.; writing—review and editing, R.G.-M.; visualization, R.G.-M.; supervision, R.G.-M.; project administration, R.G.-M.; funding acquisition, R.G.-M. All authors have read and agreed to the published version of the manuscript.

Funding

D.G.-G. is grateful to CONAHCyT-Mexico for the scholarship (824233/1233507). R.G.-M. is grateful for the financial support from UG CIIC (066/2024).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Deep, A.; Bhatia, R.K.; Kaur, R.; Kumar, S.; Jain, U.K.; Singh, H.; Batra, S.; Kaushik, D.; Deb, P.K. Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents. Curr. Top. Med. Chem. 2017, 17, 238–250. [Google Scholar] [CrossRef] [PubMed]
  2. Tomoda, H.; Hirano, T.; Saito, S.; Mutai, T.; Araki, K. Substituent effects on fluores- cent properties of imidazo [1,2- a ]pyridine-based compounds. Bull. Chem. Soc. Jpn. 1999, 72, 1327–1334. [Google Scholar] [CrossRef]
  3. Lee, J.Y.; Shim, J.Y.; Kim, H.K.; Ko, D.; Baik, M.-H.; Yoo, E.J. 3,5-Diarylimidazo[1,2- a ]Pyridines as Color-Tunable Fluorophores. J. Org. Chem. 2017, 82, 4352–4361. [Google Scholar] [CrossRef] [PubMed]
  4. Haase, J. Large-Scale Preparation and Usage of Azides. In Organic Azides; Bräse, S., Banert, K., Eds.; Wiley: Hoboken, NJ, USA, 2009; pp. 29–51. ISBN 978-0-470-51998-1. [Google Scholar]
  5. Boltjes, A.; Dömling, A. The Groebke-Blackburn-Bienaymé Reaction. Eur. J. Org. Chem. 2019, 2019, 7007–7049. [Google Scholar] [CrossRef] [PubMed]
  6. Martini, C.; Mardjan, M.I.D.; Basso, A. The Groebke–Blackburn–Bienaymé Reaction in Its Maturity: Innovation and Improvements since Its 21st Birthday (2019–2023). Beilstein J. Org. Chem. 2024, 20, 1839–1879. [Google Scholar] [CrossRef] [PubMed]
  7. Kurva, M.; Claudio-Catalán, M.Á.; Rentería-Gómez, Á.; Jiménez-Halla, J.O.C.; González-García, G.; Velusamy, J.; Ramos-Ortíz, G.; Castaño-González, K.; Piazza, V.; Gámez-Montaño, R. Multicomponent One-Pot Synthesis of Luminescent Imidazo [1,2-a]Pyridine-3-Amines. Studies of Fluorescence, Solvatochromism, TD-DFT Calculations and Bioimaging Application. J. Mol. Struct. 2023, 1276, 134797. [Google Scholar] [CrossRef]
  8. Thaltiri, V.; Singh, J.; Staples, R.J.; Shreeve, J.M. A Domino Reaction from a Sensitive Azide: The Impact of Positional Isomerism on Chemical Reactivity Featuring Ortho Azido/Nitro Substituted Derivatives. J. Mater. Chem. A 2024, 12, 9546–9551. [Google Scholar] [CrossRef]
Figure 1. Bioactive molecules containing imidazo[1,2-a]pyridine scaffold and azide group.
Figure 1. Bioactive molecules containing imidazo[1,2-a]pyridine scaffold and azide group.
Chemproc 16 00088 g001
Scheme 1. Previous report of synthesis of IMPs functionalized with azides [8].
Scheme 1. Previous report of synthesis of IMPs functionalized with azides [8].
Chemproc 16 00088 sch001
Scheme 2. Synthesis of imidazo[1,2-a]pyridine scope.
Scheme 2. Synthesis of imidazo[1,2-a]pyridine scope.
Chemproc 16 00088 sch002
Table 1. Screening conditions for the synthesis of molecule 9a.
Table 1. Screening conditions for the synthesis of molecule 9a.
Chemproc 16 00088 i001
EntrySolventCatalyst (20 mol%)TemperatureTimeYield (%)
1MeOHNH4Clr.t.24 h65
2MeOHp-TsOHr.t.24 h59
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

García-García, D.; Tovar-Rosales, J.A.; González-Gámez, I.A.; Gámez-Montaño, R. Multicomponent One-Pot Synthesis of Imidazo[1,2-a]pyridine Functionalized with Azides. Chem. Proc. 2024, 16, 88. https://doi.org/10.3390/ecsoc-28-20140

AMA Style

García-García D, Tovar-Rosales JA, González-Gámez IA, Gámez-Montaño R. Multicomponent One-Pot Synthesis of Imidazo[1,2-a]pyridine Functionalized with Azides. Chemistry Proceedings. 2024; 16(1):88. https://doi.org/10.3390/ecsoc-28-20140

Chicago/Turabian Style

García-García, Diana, Jorge Alejandro Tovar-Rosales, Indhira A. González-Gámez, and Rocío Gámez-Montaño. 2024. "Multicomponent One-Pot Synthesis of Imidazo[1,2-a]pyridine Functionalized with Azides" Chemistry Proceedings 16, no. 1: 88. https://doi.org/10.3390/ecsoc-28-20140

APA Style

García-García, D., Tovar-Rosales, J. A., González-Gámez, I. A., & Gámez-Montaño, R. (2024). Multicomponent One-Pot Synthesis of Imidazo[1,2-a]pyridine Functionalized with Azides. Chemistry Proceedings, 16(1), 88. https://doi.org/10.3390/ecsoc-28-20140

Article Metrics

Back to TopTop